Kewaunee Scientific Co. (NASDAQ:KEQU) CFO Sells $119,231.31 in Stock

Kewaunee Scientific Co. (NASDAQ:KEQU - Get Free Report) CFO Donald T. Gardner III sold 2,049 shares of the stock in a transaction on Tuesday, December 24th. The stock was sold at an average price of $58.19, for a total transaction of $119,231.31. Following the completion of the sale, the chief financial officer now directly owns 22,615 shares of the company's stock, valued at approximately $1,315,966.85. This trade represents a 8.31 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website.

Kewaunee Scientific Price Performance

Shares of Kewaunee Scientific stock traded up $2.52 on Thursday, hitting $63.62. 42,953 shares of the company traded hands, compared to its average volume of 17,414. The company has a debt-to-equity ratio of 0.48, a quick ratio of 2.00 and a current ratio of 2.53. The business has a 50-day simple moving average of $41.35 and a 200 day simple moving average of $42.98. Kewaunee Scientific Co. has a 52 week low of $26.41 and a 52 week high of $66.15. The stock has a market capitalization of $182.72 million, a P/E ratio of 10.08 and a beta of 0.80.

Wall Street Analyst Weigh In

Separately, StockNews.com raised Kewaunee Scientific from a "hold" rating to a "buy" rating in a research note on Wednesday, December 18th.

Institutional Investors Weigh In On Kewaunee Scientific

Several large investors have recently made changes to their positions in KEQU. JPMorgan Chase & Co. lifted its position in Kewaunee Scientific by 18,000.0% during the third quarter. JPMorgan Chase & Co. now owns 905 shares of the technology company's stock valued at $30,000 after purchasing an additional 900 shares during the last quarter. Geode Capital Management LLC raised its position in shares of Kewaunee Scientific by 8.9% during the 3rd quarter. Geode Capital Management LLC now owns 23,784 shares of the technology company's stock valued at $792,000 after buying an additional 1,941 shares in the last quarter. Ritholtz Wealth Management lifted its holdings in shares of Kewaunee Scientific by 24.6% in the 3rd quarter. Ritholtz Wealth Management now owns 10,913 shares of the technology company's stock valued at $363,000 after acquiring an additional 2,156 shares during the last quarter. Barclays PLC purchased a new position in Kewaunee Scientific in the third quarter worth about $121,000. Finally, Heron Bay Capital Management bought a new stake in Kewaunee Scientific during the second quarter worth approximately $252,000. 32.69% of the stock is owned by institutional investors.

About Kewaunee Scientific

Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks.